Improved Attainment of Blood Pressure and Cholesterol Goals Using Single-Pill Amlodipine/Atorvastatin in African Americans: The CAPABLE Trial

Flack, John M.; Victor, Ronald; Watson, Karol; Ferdinand, Keith C.; Saunders, Elijah; Tarasenko, Lisa; Jamieson, Michael J.; Shi, Harry; Bruschi, Pia
January 2008
Mayo Clinic Proceedings;Jan2008, Vol. 83 Issue 1, p35
Academic Journal
OBJECTIVE: To investigate the efficacy and safety of single-pill amlodipine/atorvastatin therapy for the simultaneous treatment of hypertension (HTN) and dyslipidemia in African Americans. PATIENTS AND METHODS: Conducted between July 19, 2004, and August 9, 2005, the Clinical Utility of Caduet in Simultaneously Achieving Blood Pressure and Lipid End Points trial was a 20-week, open-label, noncomparative, muiticenter trial of the efficacy and safety of single-pill amlodipine/atorvastatin in controlling elevated blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C) In African Americans with concomitant HTN and dyslipidemia and either no additional risk factors, 1 or more cardiovascular risk factors, or coronary heart disease or a risk equivalent. Eight dosage strengths of single-pill amlodipine/atorvastatin were flexibly titrated. The primary efficacy assessment of the main trial was the percentage of patients who attained the LDL-C treatment goals of both the Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and the National Cholesterol Education Program Adult Treatment Panel Ill. RESULTS: Of the 1170 African American patients screened, 501 were enrolled in the study and 499 received drug therapy. At end point, 236 (48.3%) of 489 patients reached both their BP and LDL- C goals (vs 4 [0.8%] of 484 at baseline); 280 (56.8%) of 493 reached BP goals (vs 7 [14%] of 494 at baseline); and 361 (73.7%) of 490 reached LDL-C goals (vs 138 [28.5%] of 484 at baseline). Among the 499 patients receiving drug therapy, common treatment-related adverse events were peripheral edema (17 patients [3.4%]), headache (11 [2.2%]), myalgia (11 [2.2%]), and constipation (10 [2.0%]). CONCLUSION: Single-pill amlodipine/atorvastatin therapy was well tolerated and effectively targeted HTN and dyslipidemia in this population of African Americans who were at risk of cardiovascular disease.


Related Articles

  • Hypertension.  // Ebony;Jul2004, Vol. 59 Issue 9, p78 

    Provides information on hypertension. Risk factors for hypertension; Ratio of African Americans who have hypertension; Changes made to the guidelines for high blood pressure; Factors that can contribute to the development of hypertension.

  • Myoglobinemia is an Early and Quantitative Index of Acute Myocardial Infarction. Willerson, James T. // Angiology;May1978, Vol. 29 Issue 5, p386 

    Systemic arterial compliance was measured in 22 patients with permanent essential hypertension and compared with 11 sex- and age-matched normal subjects. Determinations were made from analysis of the monoexponential blood pressure-time curve during diastole, according to a simple visco-elastic...

  • The saltshaker's curse. Diamond, Jared // Natural History;Oct91, Vol. 100 Issue 10, p20 

    Suggests that physiological adaptations which helped American blacks survive slavery may now be predisposing their descendants to hypertension. Health problems faced by blacks; Problems associated with high blood pressure and hypertension; Relationship between salt intake and high blood...

  • An introduction to hypertension. Warren, Ed // Practice Nurse;4/11/2008, Vol. 35 Issue 7, p14 

    The article offers information for nurses on hypertension. When blood pressure (BP) is too high, this results in an extra risk of heart attack, stroke and kidney failure. The two most important consequences of high BP are coronary heart disease and cerebrovascular disease. In primary or...

  • HIGH CARDIAC OUTPUT HYPERTENSIONS. Frohlich, Edward D. // Angiology;Jul/Aug1976, Vol. 27 Issue 7, p475 

    Hyperkinetic circulation, as it is related to the clinical hypertensive diseases, is defined and its implications interpreted. These pathophysiological considerations have an important bearing in understanding the pressor mechanisms underlying hypertension and the application of therapy. Another...

  • Prescribing Update. Mead, Mike // Update;9/24/2004, Vol. 69 Issue 4, p118 

    This article presents information related to the treatment of hypertension. To prevent cardiovascular disease, the people should aim for full 24-hour control of a patient's blood pressure (BP), yet this is often not achieved. Maintaining only 18 hours of control leaves the patient exposed to 6...

  • Healthier Ways of Treating and Beating High Blood Pressure. Murphree, Rodger // American Chiropractor;Jun2009, Vol. 31 Issue 6, p16 

    The article focuses on the ways of treating high blood pressure or hypertension. Accordingly, it presents the definition of hypertension and its common anti-hypertensive medications which includes calcium channel blockers and angiotensin-converting enzyme inhibitors. It then discusses the...

  • Antihypertensive therapy: nocturnal dippers and nondippers. Do we treat them differently? Mahabala, Chakrapani; Kamath, Padmanabha; Bhaskaran, Unnikrishnan; Pai, Narasimha D.; Pai, Aparna U. // Vascular Health & Risk Management;2013, Vol. 9, p125 

    Hypertension is a major independent risk factor for cardiovascular diseases. Management of hypertension is generally based on office blood pressure since it is easy to determine. Since casual blood pressure readings in the office are influenced by various factors, they do not represent basal...

  • Antihypertensive Efficacy of Olmesartan Medoxomil and Candesartan Cilexetil in Achieving 24-Hour Blood Pressure Reductions and Ambulatory Blood Pressure Goals. Brunner, Hans R.; Arakawa, Kikuo // Clinical Drug Investigation;2006, Vol. 26 Issue 4, p185 

    BACKGROUND: For patients with hypertension, effective 24-hour blood pressure (BP) control is vital to ensure protection against the early morning surge in BP and the associated increased risk of cardiovascular events. The aim of this analysis was to assess the 24-hour antihypertensive efficacy...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics